Nexo Therapeutics, Inc.
Littleton, US · Founded 2022 · Delaware corporation · 2 known investors
Find your way into Nexo Therapeutics, Inc.
16 people in our graph share verified history with the Nexo Therapeutics, Inc. team — schools, employers, funds. One of them is your warm intro.
Eric Andersonunlockedknows Andrew Phillips · together at Domino's (overlapped)
×3knows the team · via Kmart Corporation
×6knows the team · via Domino's
×2knows the team · via West Chester University of Pennsylvania
Founders & leadership
AP
Andrew PhillipsinExecutiveAndrew Phillips holds a bachelor's degree in pharmaceutical product development with minors in biology and chemistry from West Chester University, and has prior experience in the discovery, optimization, production, and purification of therapeutic antibodies using molecular biology and cell culture techniques.
Board
AB
CR
Investors · 2
Reported raises · per SEC filings
Form D private placements$60M disclosed across 1 round · 2022
▶$60MraisedMar 2026 · 7 investors · BiotechnologyRule 506(b)
▶$60MraisedMar 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ali BehbahaniDirector
- Andrew PhillipsExecutive Officer, Director
- Carlo RizzutoDirector
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nexo Therapeutics, Inc.'s investors?
- Nexo Therapeutics, Inc.'s investors include New Enterprise Associates (NEA), Versant Ventures.
- How much funding has Nexo Therapeutics, Inc. raised?
- Nexo Therapeutics, Inc. has disclosed $60M raised across 1 round.
- Where is Nexo Therapeutics, Inc. headquartered?
- Nexo Therapeutics, Inc. is headquartered in Littleton, US.